We also identify a PAX3-FOXO1 binding region near the MYOD-bound SKP2 enhancer in FP-RMS cells suggesting that both MYOD and PAX3-FOXO1 participate in the induction of SKP2 in this tumor subtype, possibly as components of a core transcription TFs complex20. The gene discussed is SKP2; the disease is neoplasm.